New asthma inhaler shows promise in early trial

NCT ID NCT06644924

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a single dose of a new albuterol inhaler called PT007 in 118 adults with asthma. Researchers compared how well it opened airways and its safety against a placebo inhaler and the standard Ventolin inhaler. The goal is to see if PT007 works as a quick-relief treatment for asthma symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Albuterol Sulfate (PT007 inhaler)
What this could lead to: If successful, PT007 could offer a new rescue inhaler option for asthma patients to quickly open airways during attacks.
What could go wrong: This is an early Phase 2 trial with only 118 participants, so results may not apply to everyone. The drug is similar to existing albuterol inhalers, so major breakthroughs are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma bronchial disorder lung disorder obstructive lung disease Respiratory Hypersensitivity respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Research Site

Encinitas, California, 92024, United States
Research Site

Lancaster, California, 93534, United States
Research Site

Los Angeles, California, 90048, United States
Research Site

Newport Beach, California, 92663, United States
Research Site

San Diego, California, 92123, United States
Research Site

San Jose, California, 95117, United States
Research Site

Stockton, California, 95207, United States
Research Site

Clearwater, Florida, 33765, United States
Research Site

Miami, Florida, 33175, United States
Research Site

Tallahassee, Florida, 32308, United States
Research Site

Tampa, Florida, 33607, United States
Research Site

White Marsh, Maryland, 21162, United States
Research Site

Columbia, Missouri, 65203, United States
Research Site

Saint Charles, Missouri, 63301, United States
Research Site

St Louis, Missouri, 63141, United States
Research Site

Raleigh, North Carolina, 27607, United States
Research Site

Medford, Oregon, 97504, United States
Research Site

Portland, Oregon, 97202, United States
Research Site

Austin, Texas, 78759, United States
Research Site

El Paso, Texas, 79912, United States
Research Site

Victoria, Texas, 77901, United States
Research Site

Milwaukee, Wisconsin, 53228, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.